Mabylon Ag logo
VerifiedBiotechnology Research· Founded 2015

Mabylon Ag

Mabylon AG, a clinical-stage biotech company, is leading innovation in antibody-based treatments for severe allergies, inflammation, and neurological disorders. Our B-cell screening platform rapidly identifies natural human antibodies with high specificity and therapeutic potential. MY006, our first-in-class multispecific antibody therapeutic for peanut allergy, is tackling the growing food allergy market

7-day free trial · no credit card

HeadquartersSchlieren, SwitzerlandEmployees21(11 to 50)Founded year2015Websitemabylon.comLinkedIn profileLinkedIn

Verified contacts

21

available on Kipplo

LinkedIn employees

21

11 to 50 range

Open roles

no listings

Distinct roles

16

indexed titles

Tech stack

0

tools in use

Monthly traffic

organic / mo

Sign up free to see all 21 verified contacts at Mabylon Ag

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Decision-makers and verified team members

21 contacts with verified email or phone · masked until revealed.

Sign up free →

Top roles at Mabylon Ag

16 distinct titles indexed · top 10 shown.

  • 4research associate
  • 2scientist neurobiology
  • 2scientist, immunology
  • 1business development associate
  • 1chairman of the board
  • 1chief operating officer
  • 1executive vice president immuno
  • 1executive vice president molecular biology
  • 1office manager
  • 1research associate molecular biology
  • +6more titles

Sign up to unlock all 21 contacts at Mabylon Ag

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Sign up to reveal 21 verified contacts at Mabylon Ag

7-day trial · no credit card · cancel anytime · only pay for verified records.

Trusted by sales, marketing, and GTM engineering teams.

Mabylon Ag | Kipplo Discover